Coherus Identifies Stealing Amgen’s Crown As Pegfilgrastim Market Leader

Plans To Avoid ‘Resorting To Disproportionate Discounting’ Of Other Biosimilars

Arrows
Coherus is aiming to rise above innovator Amgen • Source: Shutterstock

More from Biosimilars

More from Products